36.79 0.00 (0.00%)
After hours: 5:01PM EST
|Bid||0.00 x 800|
|Ask||0.00 x 1300|
|Day's Range||36.45 - 36.94|
|52 Week Range||31.68 - 63.04|
|Beta (3Y Monthly)||0.83|
|PE Ratio (TTM)||9.88|
|Earnings Date||Feb 7, 2019|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||42.71|
# MEDNAX Inc ### NYSE:MD View full report here! ## Summary * Bearish sentiment is low ## Bearish sentiment Short interest | Positive Short interest is low for MD with fewer than 5% of shares on loan. The last change in the short interest score occurred more than 1 month ago and implies that there has been little change in sentiment among investors who seek to profit from falling equity prices. ## Money flow ETF/Index ownership | Neutral ETF activity is neutral. The net inflows of $5.31 billion over the last one-month into ETFs that hold MD are not among the highest of the last year and have been slowing. ## Economic sentiment PMI by IHS Markit | Neutral According to the latest IHS Markit Purchasing Managers' Index (PMI) data, output in the Healthcare sector is rising. The rate of growth is strong relative to the trend shown over the past year, but is easing. ## Credit worthiness Credit default swap CDS data is not available for this security. Please send all inquiries related to the report to email@example.com. Charts and report PDFs will only be available for 30 days after publishing. This document has been produced for information purposes only and is not to be relied upon or as construed as investment advice. To the fullest extent permitted by law, IHS Markit disclaims any responsibility or liability, whether in contract, tort (including, without limitation, negligence), equity or otherwise, for any loss or damage arising from any reliance on or the use of this material in any way. Please view the full legal disclaimer and methodology information on pages 2-3 of the full report.
MEDNAX, Inc. (MD), will host an investor conference call and webcast on Thursday, February 7, 2019 at 10:00 a.m. ET, to discuss results from operations for the quarter and the twelve months ended December 31, 2018. The investor conference call will be webcast and can be accessed at MEDNAX’s website, www.mednax.com/investors. MEDNAX, Inc. is a national health solutions partner comprised of the nation's leading providers of physician services.
While some investors are already well versed in financial metrics (hat tip), this article is for those who would like to learn about Return On Equity (ROE) and why it Read More...
While HCA Healthcare (HCA) has been a runaway winner this year, other companies by virtue of strong operating fundamentals are poised for growth in 2019.
According to the GuruFocus All-In-One Screener, the following companies have grown their book value per share (BV/S) over the last decade. BV/S is calculated as total equity minus preferred stock, divided by shares outstanding. Since the BV/S may not reflect the company's true value, some investors check the tangible book value to confirm their investment ideas.
MEDNAX, Inc. (MD), the national medical group specializing in neonatology, anesthesiology, radiology, maternal-fetal medicine, other pediatric physician services, and management services, today announced that it has completed the $250 million accelerated share repurchase (ASR) program previously announced on September 4, 2018. Under the terms of the ASR, the Company repurchased approximately 5.9 million shares of its common stock at an average price of $42.47 per share. The ASR program was completed as part of the previously announced authorization by MEDNAX’s Board of Directors to repurchase up to $500 million of the Company’s common stock.
Does Mednax Inc. (NYSE:MD) represent a good buying opportunity at the moment? Let’s briefly check the hedge fund interest towards the company. Hedge fund firms constantly search out bright intellectuals and highly-experienced employees and throw away millions of dollars on research activities, so it is no wonder why they tend to generate millions in profits […]
This article is written for those who want to get better at using price to earnings ratios (P/E ratios). We'll show how you can use MEDNAX Inc's (NYSE:MD) P/E ratio Read More...
Mednax (MD) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
MEDNAX, Inc. (MD) and MEDNAX Radiology Solutions, one of the nation’s largest radiology practices, has launched the MEDNAX Radiology Solutions Artificial Intelligence (MDR-AI) Incubator. The MDR-AI Incubator brings together radiologists, a rich clinical dataset, and a select group of technology partners that will stimulate innovation and product development in radiology, improving radiologist’s accuracy and efficiency and overall quality of patient care. There are currently 15 active partners at various levels of engagement that are already delivering value through production use of existing models within the MEDNAX Radiology Common Imaging Platform.
Third paragraph, second sentence of release should read: In addition, the group services the Bethesda Outpatient Imaging Center at Bethesda Health City and Bethesda Health Urgent Care. MEDNAX, Inc. (MD), a leading physician services and health solutions provider, today announced the acquisition of Bethesda Radiology Associates, Inc., a private radiology physician group based in Boynton Beach, Fla. The practice will integrate with Radiology Associates of South Florida, LLC, a MEDNAX-affiliated physician practice located in Miami and serving all of South Florida.
One of the nation’s largest radiology practices, recognized as a leader in radiology, launches Artificial Intelligence Incubator and Radiology Centers of Excellence programs;
MEDNAX, Inc. (MD), announced today the closing of the previously announced private placement of $500 million aggregate principal amount of its 6.250% senior notes due January 15, 2027 (the “Notes”). The completed transaction resulted in approximately $492.5 million in net proceeds to MEDNAX, which will be used to repay a portion of the indebtedness outstanding under its senior unsecured revolving credit facility. The Notes were offered to persons reasonably believed to be qualified institutional buyers pursuant to Rule 144A under the Securities Act of 1933, as amended (the “Securities Act”), and outside the United States to persons other than U.S. persons in reliance upon Regulation S under the Securities Act.
The last change in the short interest score occurred more than 1 month ago and implies that there has been little change in sentiment among investors who seek to profit from falling equity prices. Index (PMI) data, output in the Healthcare sector is rising.
Moody's Investors Service ("Moody's") assigned a Ba2 rating to MEDNAX, Inc.'s $750 million of new unsecured notes. There is no change to the Ba2 Corporate Family Rating, the Ba2-PD Probability of Default Rating, the Ba2 rating on the unsecured bonds due 2023, or SGL-1 Speculative Grade Liquidity Rating. Ratings assigned: MEDNAX, Inc.
MEDNAX, Inc. (MD), announced today that it is proposing to issue $750.0 million aggregate amount of senior notes due 2026 (the “Notes”) in a private offering that is exempt from the registration requirements of the Securities Act of 1933, as amended (the “Securities Act”). If the offering is successfully completed, MEDNAX intends to use the net proceeds from the offering to repay a portion of the indebtedness outstanding under its senior unsecured revolving credit facility. The Notes are being offered only to persons reasonably believed to be qualified institutional buyers in reliance on Rule 144A under the Securities Act and outside the United States only to non-U.S. investors pursuant to Regulation S. The Notes will not be registered under the Securities Act and may not be offered or sold in the United States absent registration or an applicable exemption from the registration requirements of the Securities Act.
If you are currently a shareholder in MEDNAX Inc (NYSE:MD), or considering investing in the stock, you need to examine how the business generates cash, and how it is reinvested. Read More...
MEDNAX's (MD) Q3 earnings grow on the back of the company's operational efficiency as well as its various growth initiatives.